You did the hard part. The next wall is capital — and Hong Kong.
SinoNordic LifeCare Fund backs validated Nordic life science companies and gives them a structured path into Hong Kong capital and markets.
More than a cheque.
We are not a passive cheque. The connection into Hong Kong is the point.
Growth capital
Funding aligned with your stage, from a fund built specifically for cross-border life science.
A built route into Hong Kong
Market entry, regulatory navigation, local partnerships, and commercial and manufacturing scale — the access most companies cannot assemble alone.
The hard parts handled
We carry the cross-border engineering: structuring, IP protection, and governance, so you can keep building.
The companies we build for.
- Nordic life science & healthcare: medtech, biotech, diagnostics, digital health.
- Past the science risk — a credible clinical or commercial signal, not just a concept.
- Scale-stage: ready to grow, constrained by capital and/or market reach.
- Clear Hong Kong relevance: a product a large, ageing, fast-growing market actually needs.
- Defensible intellectual property.
Not quite there yet? We are still glad to hear from you early.
From first conversation to scale.
- 01
Conversation
A confidential first discussion about your company and ambitions.
- 02
Fit & diligence
We assess the science, the Hong Kong relevance, and the right structure.
- 03
Structure
We build the vehicle that protects your IP and aligns everyone.
- 04
Capital + access
Funding paired with a concrete Hong Kong entry plan.
- 05
Scale
Execution into the Hong Kong market, together.
Your intellectual property is the company, and we treat it that way. First conversations are held in confidence, and any structure we propose is designed to protect core IP rather than expose it — a non-negotiable for us and for our investors alike.
Tell us about your company.
A short note is enough to start a conversation. We'll reply personally.